Thirty-year outcomes of the national hepatitis B immunization program in Taiwan.
about
Lessons learnt over two decades of vaccination against hepatitis B in ItalyHepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genesSignificance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinomaWeaknesses and Pitfalls of Using Mice and Rats in Cancer Chemoprevention StudiesMolecular cancer prevention: Current status and future directionsHepatocellular carcinoma: a reviewComparison of hepatocellular carcinoma in Eastern versus Western populations.Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: a review.Efficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30-year follow-up of the Qidong hepatitis B intervention study: a cluster randomized controlled trial.Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults.Seroprevalence of hepatitis B virus among adults at high risk for HIV transmission two decades after implementation of nationwide hepatitis B virus vaccination program in Taiwan.Prevention of hepatitis B.International trends in primary liver cancer incidence from 1973 to 2007.Personalized management of hepatocellular carcinoma based on molecular information: future prospects.Long-term Realism and Cost-effectiveness: Primary Prevention in Combatting Cancer and Associated Inequalities Worldwide.Substantial decline in hepatitis B virus infections following vaccine introduction in TajikistanGlobal epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability.Hepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care.Transforming Cancer Prevention through Precision Medicine and Immune-oncology.Cancer statistics for Asian Americans, Native Hawaiians, and Pacific Islanders, 2016: Converging incidence in males and females.Improving clinical outcomes of chronic hepatitis B virus infection.Hepatitis B: 50 years after the discovery of Australia antigen.The immunogenicity of GSK's recombinant hepatitis B vaccine in children: a systematic review of 30 years of experience.Immunogenicity, effectiveness and safety of combined hepatitis A and B vaccine: a systematic literature review.Potential applications of nanoparticles in cancer immunotherapy.Systematic review with meta-analysis: the efficacy and safety of tenofovir to prevent mother-to-child transmission of hepatitis B virus.Acute Hepatitis B After the Implementation of Universal Vaccination in Italy: Results From 22 Years of Surveillance (1993-2014).Cancer of childhood in sub-Saharan Africa.[Vaccination against hepatitis B: success and challenges].[Hepatitis B vaccination: a review].Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.Significant reduction in end-stage liver diseases burden through the national viral hepatitis therapy program in Taiwan.Realizing the Potential of Cancer Prevention - The Role of Implementation Science.Incomplete hepatitis B immunization, maternal carrier status, and increased risk of liver diseases: a 20-year cohort study of 3.8 million vaccinees.Delayed introduction of the birth dose of Hepatitis B vaccine in EPI programs in East Africa: a missed opportunity for combating vertical transmission of Hepatitis B.Association of High-Volume Surgeons Working in High-Volume Hospitals with Cost of Free Flap Surgeries.Risk of recurrence in chronic hepatitis B patients developing hepatocellular carcinoma with antiviral secondary prevention failure.The mutation of hepatitis B virus and the prognosis of hepatocellular carcinoma after surgery: a pilot study.Breast Cancer Prevention: Current Approaches and Future Directions
P2860
Q26770673-A588C881-5BBE-4C69-ADDA-4D478513D8DCQ26772317-12950A73-6C8E-4536-BF78-717A7048C522Q26773251-EFDC7301-BE92-454B-A65D-6C91D07AB70DQ26781102-2F75E322-A2C5-4D90-8B1E-61A7425F01E7Q26797207-6D7A61B0-B637-4883-915F-E0042EBA619FQ28069290-6CE40EF6-550B-4571-BAFF-630F5695E89DQ30245396-7C769EA7-9CD0-4F2F-B040-868A48882E60Q30391932-7916E370-D97C-42C2-888E-A930E3571CAAQ34405008-5EFBD1CF-373B-4F8B-A3CC-4817BB3C41FEQ34789906-51D09B6C-956F-4DAD-8DE7-CBC975014AFEQ35055166-2F612741-E80A-42D3-B369-69175ED2F284Q35108823-37CCFCD1-5581-409C-AD28-FFC0F8CA63D6Q35164249-3D81465A-D513-4C0B-85BD-BB0836FD1D21Q35177884-20359DD7-7132-4C95-85DB-71F9BDB78B75Q35881575-10F65C52-A955-415F-8D75-1884A89C8127Q36356696-594FAE11-9043-4330-85F9-587D7F1E3ABAQ36410313-771591F0-3517-495E-ACF7-6C23E07B0621Q36461735-67DEC0A8-CCED-41F1-8FC1-3BF858817059Q36871021-BDCA593A-354E-41A6-92F8-ED5FB231C733Q37114360-691A0CCC-5EA2-4069-885C-D7A849EA0FF3Q37665982-5AADE2BE-BAE2-4769-91A4-635EEC8BD9A3Q38252962-84961E36-091C-4D2B-AFEE-A06313A00A84Q38568256-D5CBC810-B741-468C-A5F3-68A428FD1D61Q38674210-F757F642-F26F-47F9-A379-41DDD1A426D5Q38721381-E77E25C7-A6E2-4908-A2C8-EB39C9BA5448Q39015434-5153A7A1-C921-4E9C-AAD0-9025C40EF8E5Q39258357-328AD594-BEB3-4AF4-9F24-B35D87DBD35AQ39893157-C71B8AC2-A009-4942-BCF6-3432D71742FCQ40050081-BC9FC72A-CAF8-47BA-B287-08895924A569Q40544414-BF94F2BC-A684-4D81-863C-316F88F53609Q41683102-0D00E66E-1EB7-4FAD-A3A4-693353AEACA8Q41962614-1A5A0FC0-F331-4059-B6BE-C4DA1B18B154Q42177592-75697689-A3F5-48B9-ADBB-E6DD75FAD590Q42198794-8CA9C86B-EC7D-41E2-9F8F-541DB7BF425FQ42229775-B97BEC82-3B10-46B9-BA2E-B25F1771F857Q47106660-83DF8208-1080-4282-B8B6-717C8BD3D601Q47399786-ED678A50-8EE8-4896-B92D-4DC11AFDFA56Q47695757-D948E25F-083E-497F-891B-053A0FCD149FQ52599794-57363B59-1C1E-4F2B-A472-A0C9FC43F1C5Q57113892-3BF5735C-AC72-4F7C-A457-9AB58F09065F
P2860
Thirty-year outcomes of the national hepatitis B immunization program in Taiwan.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Thirty-year outcomes of the national hepatitis B immunization program in Taiwan.
@en
Thirty-year outcomes of the national hepatitis B immunization program in Taiwan.
@nl
type
label
Thirty-year outcomes of the national hepatitis B immunization program in Taiwan.
@en
Thirty-year outcomes of the national hepatitis B immunization program in Taiwan.
@nl
prefLabel
Thirty-year outcomes of the national hepatitis B immunization program in Taiwan.
@en
Thirty-year outcomes of the national hepatitis B immunization program in Taiwan.
@nl
P50
P356
P1476
Thirty-year outcomes of the national hepatitis B immunization program in Taiwan.
@en
P2093
Chien-Jen Chen
Ya-Wen Yang
P304
P356
10.1001/JAMA.2013.276701
P407
P577
2013-09-01T00:00:00Z